Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-09-25, Stock:PFE, The news for the past five days is as follows:
2020-09-18: NEWS1: Is Pfizer Stock a Buy Right Now? This Is What You Need to Know.NEWS2: Bristol Myers' Opdivo with Exelixis drug cuts kidney cancer death risk -study.NEWS3: ‘We have to continue to be really, really vigilant’ in maintaining our health infrastructure: Dr. Amesh Adalja.NEWS4: MEDIA-Business chiefs push Cuomo, de Blasio to bolster NYC After COVID-19 pandemic- Bloomberg News.NEWS5: Johnson & Johnson stock outperforms competitors on strong trading day.NEWS6: EXPLAINER-When will COVID-19 vaccines be generally available in the U.S.?.NEWS7: Three-quarters of Americans are worried about the vaccine rush: Pew.NEWS8: Novavax Stock Is a Risky Way to Get Rich Quick.NEWS9: iBio Is a Wishful Thinkers Coronavirus Vaccine Bet.NEWS10: Why Pfizer Is Seriously Mispriced.NEWS11: Pharma Stock Roundup: AZN, LLY & PFE's Coronavirus Updates, MRK's New Cancer Deals.NEWS12: EXPLAINER-When will COVID-19 vaccines be generally available in the U.S.?.NEWS13: Unusual Options Activity Insight: Pfizer.NEWS14: Why Novartis’ Absence From the Covid-19 Vaccine Race Is a Benefit.NEWS15: Is Sorrento Stock Really Worth the Speculation?.NEWS16: Moderna CEO downplays vaccine timeline pressure: 'We don't want the first, we want the best'.NEWS17: 3 Dividend Stocks Perfect for Retirees.NEWS18: 3 Coronavirus Vaccines in Phase 3 Clinical Studies: How They Stack Up Against Each Other.NEWS19: BioNTech Investor Fortunes Rise and Fall on Headlines, Pacts and Funding.NEWS20: BAVENCIO Pivotal Phase III JAVELIN Bladder 100 Results Published in The New England Journal of Medicine.NEWS21: BAVENCIO Pivotal Phase III JAVELIN Bladder 100 Results Published in The New England Journal of Medicine.NEWS22: PRESS DIGEST- New York Times business news - Sept. 18.NEWS23: Pfizer vaccine trial bets on early win against coronavirus, documents show.
2020-09-21: NEWS1: Pfizer (PFE) Dips More Than Broader Markets: What You Should Know.NEWS2: Covid Report: AstraZeneca Now Seen As Lagging In Vaccine Race.NEWS3: Johnson & Johnson stock falls Monday, underperforms market.NEWS4: Column: Did drug makers really stand up to Trump over those 'Trump card' discounts? Doubtful.NEWS5: Anticancer Drug Team-Ups Show Promise. 4 Stocks That Stand to Gain..NEWS6: Trump suggests Pfizer could win U.S. COVID-19 vaccine approval, JNJ to come later.NEWS7: Normality could return in summer 2021 if vaccine succeeds - UK health minister.NEWS8: Pfizer Reveals Efficacy Criteria For Key Covid-19 Vaccine Trials.
2020-09-22: NEWS1: Everything you need to know about what it would take for the FDA to approve a COVID-19 vaccine.NEWS2: Johnson & Johnson stock underperforms Tuesday when compared to competitors.NEWS3: This Profitable IPO Has Soared In Value Ahead Of Pricing, Debut.NEWS4: Axsome Expedites Development Plan for Narcolepsy Candidate.NEWS5: 4 Biotechs That Have More Than Doubled Thanks to Coronavirus.NEWS6: Pfizer Invites Public to View and Listen to Webcast of October 27 Conference Call with Analysts.NEWS7: India's Serum Institute starts manufacturing Codagenix's potential COVID-19 vaccine.NEWS8: Why Pfizer's Latest Big Win Makes It an Even Better Buy for Retirees.
2020-09-23: NEWS1: The Covid-19 Vaccine Candidates That Are Now in Phase 3 Trials.NEWS2: Johnson & Johnson stock outperforms competitors on strong trading day.NEWS3: Johnson & Johnson Is Latest To Start Final-Phase Testing For Covid-19 Vaccine.NEWS4: GoodRx IPO Surges; Drug Shopping App Value Soars To $19 Billion.NEWS5: EU close to concluding preliminary talks with Novavax on COVID vaccine supply - source.NEWS6: Javelin Biotech Aims to Develop Industry-Leading &quot;Organ-on-a-Chip&quot; Predictive Pharmacokinetics Platform in Collaboration with Pfizer Inc..NEWS7: FDA commissioner: It's up to drug makers developing vaccines to seek approval or EUA.NEWS8: Fauci predicts U.S. will know if COVID-19 vaccines are effective by &quot;November or December&quot;.NEWS9: J&J Launches Trial of Single-Dose Covid Vaccine. Results Could Come Quicker Than You Think..NEWS10: MediciNova Stock Spikes on Coronavirus-Vaccine Progress.NEWS11: GoodRx IPO Prices High At $33; Profitable Drug Shopping Site Stock Set To Debut.NEWS12: Here's My Top Coronavirus Vaccine Stock to Buy.NEWS13: FDA Accepts Supplemental New Drug Application for Pfizer’s XALKORI® (crizotinib) for the Treatment of Pediatric ALK-positive Anaplastic Large Cell Lymphoma.NEWS14: J&J kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers.NEWS15: 3 Safe Coronavirus Stocks to Buy Ahead of a Market Crash.NEWS16: 2 High-Yield Dividend Stocks I'd Buy Right Now.
2020-09-24: NEWS1: All the Covid-19 Vaccine Candidates That Are Now in Final Trials.NEWS2: Novavax Starts a Phase 3 Trial of Its Covid-19 Vaccine.NEWS3: Johnson & Johnson stock rises Thursday, still underperforms market.NEWS4: Moderna Stock Can’t Go Much Higher—Even If It Makes a Covid-19 Vaccine.NEWS5: Moderna Analyst On 4 Coronavirus Vaccine Program Risks.NEWS6: Coronavirus update: Trump suggests he may overrule FDA vaccine approval; airlines ramp up testing.NEWS7: Current Updates On COVID-19 Vaccine.NEWS8: Moderna May Be Too Lofty, Even If It Makes a Covid-19 Vaccine, Analyst Says.NEWS9: Moderna May Be Too Lofty, Even If It Makes a Covid-19 Vaccine, Analyst Says.NEWS10: Pfizer Seeks Xalkori's Label Expansion, Gets Priority Review.NEWS11: Pharma Stock Roundup: J&J's Coronavirus Vaccine in Phase III, Other Updates.NEWS12: 4 Coronavirus Vaccine Makers Now in Phase III as J&J Begins Study.NEWS13: Pfizer Declares Fourth-Quarter 2020 Dividend.NEWS14: A List of All the Covid-19 Vaccine Candidates That Are Now in Final Trials.NEWS15: 4 Coronavirus Vaccine Stocks the Bill & Melinda Gates Foundation Is Betting On.NEWS16: IDEAYA and Pfizer Expand Clinical Trial Collaboration and Supply Agreement to Evaluate Clinical Combination of IDE196 and Crizotinib in Solid Tumors Harboring GNAQ or GNA11 Mutations.NEWS17: Pfizer partner BioNTech sees no role for its vaccine in UK challenge trial.

Answer: Rise